Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock

被引:123
作者
Le Tulzo, Y
Pangault, C
Amiot, L
Guilloux, V
Tribut, O
Arvieux, C
Camus, C
Fauchet, R
Thomas, R
Drénou, B
机构
[1] CHU Rennes, Hop Pontchaillou, Serv Reanimat Med & Maladies Infect, Lab Hematol & Biol Cellules Sanguines,UPRES EA 22, F-35033 Rennes, France
[2] CHU Rennes, Lab Pharmacol Clin & Expt, F-35033 Rennes, France
关键词
major histocompatibility complex type II; class II transactivator A; immune paralysis; infection;
D O I
10.1164/rccm.200309-1329OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Monocyte deactivation has been identified as a major factor of immunosuppression in sepsis and is associated with a loss of surface human leukocyte antigen-DR (HLA-DR) expression on circulating monocytes. Using flow cytometry, quantitative reverse transcription-polymerase chain reaction, we investigated this phenomenon in septic patients. We confirmed the early loss of monocyte HLA-DR expression in all infected patients and demonstrated that this persistent lowered expression at Day 6 correlated with severity scores, secondary infection, and death. This phenomenon occurred at a transcriptional level via a decrease in the class II transactivator A (CIITA) transcription. Furthermore, these abnormalities correlated with the high cortisol levels observed in sepsis and not with those of other putative factors such as catecholamines or interleukin-10. Finally, in vitro studies evidenced that glucocorticoids decrease HLA-DR expression at a transcriptional level via a decrease in CIITA mRNA levels, mainly by down modulating its isoforms I and III. We conclude that in human sepsis, the loss of HLA-DR expression on circulating monocytes is associated with a poor outcome. We suggest that the high endogenous cortisol level observed in septic shock may be a possible new factor involved in the loss of HLA-DR expression on monocytes via its effect on HLA-DR and CIITA transcription.
引用
收藏
页码:1144 / 1151
页数:8
相关论文
共 41 条
[1]   A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin [J].
Annane, D ;
Sébille, V ;
Troché, G ;
Raphaël, JC ;
Gajdos, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (08) :1038-1045
[2]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[3]  
Asadullah K, 1995, Eur J Emerg Med, V2, P184, DOI 10.1097/00063110-199512000-00003
[4]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[5]   Regulation of transcription of MHC class II genes [J].
Boss, JM .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :107-113
[6]  
Carr R, 2003, COCHRANE DB SYST REV, V2003, DOI 10.1002/14651858.CD003066
[7]   Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis [J].
Cheng, AC ;
Stephens, DP ;
Anstey, NM ;
Currie, BJ .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (01) :32-37
[8]   Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: High sensitivity of TNF alpha and resistance of IL-6 [J].
DeRijk, R ;
Michelson, D ;
Karp, B ;
Petrides, J ;
Galliven, E ;
Deuster, P ;
Paciotti, G ;
Gold, PW ;
Sternberg, EM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2182-2191
[9]   Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment [J].
Docke, WD ;
Randow, F ;
Syrbe, U ;
Krausch, D ;
Asadullah, K ;
Reinke, P ;
VolK, HD ;
Kox, W .
NATURE MEDICINE, 1997, 3 (06) :678-681
[10]   In vivo effect of rhGM-CSF and rhG-CSF on monocyte HLA-DR expression of septic neonates [J].
Drossou-Agakidou, V ;
Kanakoudi-Tsakalidou, F ;
Sarafidis, K ;
Tzimouli, V ;
Taparkou, A ;
Kremenopoulos, G ;
Germenis, A .
CYTOKINE, 2002, 18 (05) :260-265